Literature DB >> 28705312

Community-Based Lifestyle Intervention in Patients With Coronary Artery Disease: The RESPONSE-2 Trial.

Madelon Minneboo1, Sangeeta Lachman1, Marjolein Snaterse2, Harald T Jørstad1, Gerben Ter Riet3, S Matthijs Boekholdt1, Wilma J M Scholte Op Reimer4, Ron J G Peters5.   

Abstract

BACKGROUND: Among patients with coronary artery disease (CAD), improvement of lifestyle-related risk factors (LRFs) reduces cardiovascular morbidity and mortality. However, modification of LRFs is highly challenging.
OBJECTIVES: This study sought to evaluate the impact of combining community-based lifestyle programs with regular hospital-based secondary prevention.
METHODS: The authors performed a randomized controlled trial of nurse-coordinated referral of patients and their partners to 3 widely available community-based lifestyle programs, in 15 hospitals in the Netherlands. Patients admitted for acute coronary syndrome and/or revascularization, with ≥1 LRF (body mass index >27 kg/m2, self-reported physical inactivity, and/or smoking) were included. All patients received guideline-based usual care. The intervention was based on 3 lifestyle programs for weight reduction, increasing physical activity, and smoking cessation. The primary outcome was the proportion of success at 12 months, defined as improvement in ≥1 qualifying LRF using weight (≥5% reduction), 6-min-walking distance (≥10% improvement), and urinary cotinine (200 ng/ml detection limit) without deterioration in the other 2.
RESULTS: The authors randomized 824 patients. Complete data on the primary outcome were available in 711 patients. The proportion of successful patients in the intervention group was 37% (133 of 360) compared with 26% (91 of 351) in the control group (p = 0.002; risk ratio: 1.43; 95% confidence interval: 1.14 to 1.78). In the intervention group, partner participation was associated with a significantly greater success rate (46% vs. 34%; p = 0.03).
CONCLUSIONS: Among patients with coronary artery disease, nurse-coordinated referral to a comprehensive set of community-based, widely available lifestyle interventions, with optional partner participation, leads to significant improvements in LRFs. (RESPONSE-2: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists 2; NTR3937).
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RESPONSE-2; comprehensive lifestyle intervention; coronary artery disease; health behavior; improvement of physical activity; nurse-coordinated care; secondary prevention; smoking cessation; weight reduction

Mesh:

Year:  2017        PMID: 28705312     DOI: 10.1016/j.jacc.2017.05.041

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Does outpatient cardiac rehabilitation help patients with acute myocardial infarction quit smoking?

Authors:  David A Katz; Donna M Buchanan; Mark W Vander Weg; Babalola Faseru; Philip A Horwitz; Philip G Jones; John A Spertus
Journal:  Prev Med       Date:  2018-10-11       Impact factor: 4.018

Review 2.  Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.

Authors:  Monika Gawałko; Thomas A Agbaedeng; Arnela Saljic; Dominik N Müller; Nicola Wilck; Renate Schnabel; John Penders; Michiel Rienstra; Isabelle van Gelder; Thomas Jespersen; Ulrich Schotten; Harry J G M Crijns; Jonathan M Kalman; Prashanthan Sanders; Stanley Nattel; Dobromir Dobrev; Dominik Linz
Journal:  Cardiovasc Res       Date:  2022-08-24       Impact factor: 13.081

Review 3.  Exercise-based cardiac rehabilitation for coronary heart disease.

Authors:  Grace Dibben; James Faulkner; Neil Oldridge; Karen Rees; David R Thompson; Ann-Dorthe Zwisler; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2021-11-06

Review 4.  Physical Activity in the Prevention and Treatment of Coronary Artery Disease.

Authors:  Ephraim Bernhard Winzer; Felix Woitek; Axel Linke
Journal:  J Am Heart Assoc       Date:  2018-02-08       Impact factor: 5.501

5.  Stable atypical chest pain with negative anatomical or functional diagnostic test: Diagnosis no matter what or prevention at any cost?

Authors:  Deborah Cosmi; Beatrice Mariottoni; Franco Cosmi
Journal:  Clin Cardiol       Date:  2019-08-20       Impact factor: 2.882

6.  The Cardiac Care Bridge randomized trial in high-risk older cardiac patients: A mixed-methods process evaluation.

Authors:  Lotte Verweij; Denise F Spoon; Michel S Terbraak; Patricia Jepma; Ron J G Peters; Wilma J M Scholte Op Reimer; Corine H M Latour; Bianca M Buurman
Journal:  J Adv Nurs       Date:  2021-02-17       Impact factor: 3.187

Review 7.  Lifestyle management to prevent atherosclerotic cardiovascular disease: evidence and challenges.

Authors:  T J van Trier; N Mohammadnia; M Snaterse; R J G Peters; H T Jørstad; W A Bax
Journal:  Neth Heart J       Date:  2021-11-11       Impact factor: 2.380

8.  Lifestyle modification in older versus younger patients with coronary artery disease.

Authors:  Patricia Jepma; Harald T Jorstad; Marjolein Snaterse; Gerben Ter Riet; Hans Kragten; Sangeeta Lachman; Madelon Minneboo; S Matthijs Boekholdt; Ron J Peters; Wilma Scholte Op Reimer
Journal:  Heart       Date:  2020-03-16       Impact factor: 5.994

Review 9.  Novel advances in cardiac rehabilitation : Position paper from the Working Group on Preventive Cardiology and Cardiac Rehabilitation of the Netherlands Society of Cardiology.

Authors:  T Vromen; R W M Brouwers; H T Jorstad; R A Kraaijenhagen; R F Spee; M E Wittekoek; M J Cramer; J M C van Hal; L Hofstra; P M J C Kuijpers; E C de Melker; S F Rodrigo; M Sunamura; N H M K Uszko-Lencer; H M Kemps
Journal:  Neth Heart J       Date:  2021-06-10       Impact factor: 2.380

Review 10.  Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention: JACC Health Promotion Series.

Authors:  Peter E H Schwarz; Patrick Timpel; Lorenz Harst; Colin J Greaves; Mohammed K Ali; Jeffrey Lambert; Mary Beth Weber; Mohamad M Almedawar; Henning Morawietz
Journal:  J Am Coll Cardiol       Date:  2018-10-09       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.